Cytokinetics prices convertible debt offering; shares down 2%

• Cytokinetics (CYTK -1.5%) prices its upsized $120M (from $100M) offering of 4.00% convertible senior notes due 2026 at par.
• The initial conversion rate will be 94.7811 common shares per $1,000 principal amount of the notes (~$10.55/share).
• Closing date is November 13.